Inbec怎么吃呢?
AIDS is an extremely harmful infectious disease caused by infection with the AIDS virus (HIV). HIV is a virus that attacks the body's immune system. It takes the most important CD4 T lymphocytes in the human immune system as its main attack target, destroys these cells in large quantities, and causes the human body to lose its immune function. Therefore, the human body is susceptible to various diseases, and malignant tumors can occur, with a high mortality rate. Suimeike (is a three-in-one compound drug used to treat HIV. It is the first single-pill compound preparation with a complete treatment plan in the field of HIV treatment in mainland China. It has the characteristics of high efficiency, good tolerance, high resistance barrier and few drug interactions.
The ingredients of Inbec are dolutegravir 50mg + abacavir 0.6g + lamivudine 0.3g. Three drugs are used for the treatment of HIV-1 infection. It is the only three-in-one compound drug containing dolutegravir. It is suitable for the treatment of adults and adolescents over 12 years old (with a weight of at least 40kg) infected with human immunodeficiency virus (HIV).
The dosage of Inbec is quite special, the weight of adults and adolescents is at least 40kg. Trimax is a fixed-dose tablet and cannot be used in patients who require dose adjustment. If one of the active ingredients needs to be discontinued or its dose adjusted, a separate formulation of dolutegravir, abacavir or lamivudine can be used. If you need to change medications, please consult your doctor first.
For adults and adolescents, the recommended dose of Inbec is one tablet once daily. Adults or adolescents whose body weight is less than 40 kg should not be given Inbec because Inbec is a fixed-dose tablet and the dose cannot be reduced.
If the patient misses a dose of Inbec and there are more than 4 hours left before the next dose, he should take Inbec as soon as possible. If the next dose is less than 4 hours away, patients should not take the missed dose and simply resume their usual dosing schedule.
[ 免责声明 ] 本页面内容来自公开渠道(如FDA官网、Drugs官网、原研药厂官网等),仅供持有医疗专业资质的人员用于医学药学研究参考,不构成任何治疗建议或药品推荐。所涉药品可能未在中国大陆获批上市,不适用于中国境内销售和使用。如需治疗,请咨询正规医疗机构。本站不提供药品销售或代购服务。
.jpeg)